1. Home
  2. PCRX vs CYH Comparison

PCRX vs CYH Comparison

Compare PCRX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • CYH
  • Stock Information
  • Founded
  • PCRX 2006
  • CYH 1985
  • Country
  • PCRX United States
  • CYH United States
  • Employees
  • PCRX N/A
  • CYH N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • CYH Hospital/Nursing Management
  • Sector
  • PCRX Health Care
  • CYH Health Care
  • Exchange
  • PCRX Nasdaq
  • CYH Nasdaq
  • Market Cap
  • PCRX 1.2B
  • CYH 440.4M
  • IPO Year
  • PCRX 2011
  • CYH 1991
  • Fundamental
  • Price
  • PCRX $26.88
  • CYH $3.36
  • Analyst Decision
  • PCRX Buy
  • CYH Hold
  • Analyst Count
  • PCRX 10
  • CYH 6
  • Target Price
  • PCRX $29.30
  • CYH $4.40
  • AVG Volume (30 Days)
  • PCRX 892.8K
  • CYH 1.9M
  • Earning Date
  • PCRX 02-27-2025
  • CYH 02-18-2025
  • Dividend Yield
  • PCRX N/A
  • CYH N/A
  • EPS Growth
  • PCRX N/A
  • CYH N/A
  • EPS
  • PCRX N/A
  • CYH N/A
  • Revenue
  • PCRX $694,957,000.00
  • CYH $12,551,000,000.00
  • Revenue This Year
  • PCRX $5.14
  • CYH $1.16
  • Revenue Next Year
  • PCRX $2.44
  • CYH $1.18
  • P/E Ratio
  • PCRX N/A
  • CYH N/A
  • Revenue Growth
  • PCRX 4.40
  • CYH 0.81
  • 52 Week Low
  • PCRX $11.16
  • CYH $2.51
  • 52 Week High
  • PCRX $31.67
  • CYH $6.29
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 77.75
  • CYH 45.86
  • Support Level
  • PCRX $25.06
  • CYH $3.20
  • Resistance Level
  • PCRX $27.10
  • CYH $3.39
  • Average True Range (ATR)
  • PCRX 1.45
  • CYH 0.16
  • MACD
  • PCRX 0.28
  • CYH 0.02
  • Stochastic Oscillator
  • PCRX 86.23
  • CYH 47.14

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: